TNSN96037A1 - TREATMENT OF ECZEMA - Google Patents

TREATMENT OF ECZEMA

Info

Publication number
TNSN96037A1
TNSN96037A1 TNTNSN96037A TNSN96037A TNSN96037A1 TN SN96037 A1 TNSN96037 A1 TN SN96037A1 TN TNSN96037 A TNTNSN96037 A TN TNSN96037A TN SN96037 A TNSN96037 A TN SN96037A TN SN96037 A1 TNSN96037 A1 TN SN96037A1
Authority
TN
Tunisia
Prior art keywords
eczema
treatment
phenylalanine
ester
acethyl
Prior art date
Application number
TNTNSN96037A
Other languages
French (fr)
Inventor
Uta Schallreuter-Wood Karin
Martin Wood John
Original Assignee
Stiefel Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Laboratories filed Critical Stiefel Laboratories
Publication of TNSN96037A1 publication Critical patent/TNSN96037A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate

Abstract

DES ESTERS L-PHENYLALANINE SUBSTITUE -N HYDROLYSABLES ET HOMOPOLAIRES SONT APPLIQUES SUR LA PEAU POUR TRAITER L'ECZEMA. L'ESTER PREFERE EST L'ESTER N-ACETHYL-L-PHENYLALANINE D'ETHYLE.HYDROLYSABLE AND HOMOPOLAR L-PHENYLALANINE SUBSTITUTED ESTERS ARE APPLIED TO THE SKIN TO TREAT ECZEMA. THE PREFERRED ESTER IS ETHYL N-ACETHYL-L-PHENYLALANINE ESTER.

TNTNSN96037A 1995-03-06 1996-03-06 TREATMENT OF ECZEMA TNSN96037A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9504444A GB2299505A (en) 1995-03-06 1995-03-06 Treatment of eczema with N-acyl-L-phenylalanine esters

Publications (1)

Publication Number Publication Date
TNSN96037A1 true TNSN96037A1 (en) 2005-03-15

Family

ID=10770701

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96037A TNSN96037A1 (en) 1995-03-06 1996-03-06 TREATMENT OF ECZEMA

Country Status (6)

Country Link
AU (1) AU4884796A (en)
GB (1) GB2299505A (en)
IL (1) IL117365A0 (en)
TN (1) TNSN96037A1 (en)
WO (1) WO1996027373A1 (en)
ZA (1) ZA961785B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060251597A1 (en) * 2005-05-04 2006-11-09 Yu Ruey J Anti-odor compositions and therapeutic use
WO2021142514A1 (en) * 2020-01-13 2021-07-22 Monash University Compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5982310A (en) * 1982-11-04 1984-05-12 Shiseido Co Ltd Pack cosmetic
JPH03181417A (en) * 1989-12-12 1991-08-07 Nikko:Kk Local antimicrobial agent
JPH0632727A (en) * 1992-07-15 1994-02-08 Kao Corp External preparation for skin

Also Published As

Publication number Publication date
WO1996027373A1 (en) 1996-09-12
GB9504444D0 (en) 1995-04-26
AU4884796A (en) 1996-09-23
ZA961785B (en) 1996-10-24
IL117365A0 (en) 1996-07-23
GB2299505A (en) 1996-10-09

Similar Documents

Publication Publication Date Title
FR2749759B1 (en) USE OF STRONTIUM SALTS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROSIS
ATE89738T1 (en) ANTI-INFLAMMATORY.
HUP9904665A3 (en) Immune response modifier compounds for treatment of th2 mediated and related diseases
FI963692A0 (en) Methods and compositions useful for inhibiting angiogenesis
DK0880350T3 (en) Treatment of disseminated sclerosis
DK0774962T3 (en) Use of DHA in the treatment of dyslexia
ZA966886B (en) Methods and compositions useful for inhibition of alphavbeta5 mediated
ID21858A (en) COMPOSITIONS OF SKIN CARE CONTAINING AMIDA AND RETINOID
BR8806790A (en) WATER COATING COMPOSITION AND WATER DISPERSION OF POLYMER PARTICLES
ES2183013T3 (en) HYDROSOLUBLE FILMS.
EP0497275A3 (en) Generation of cd4+ helper t cells with interleukin 2 and interleukin 4 from l-phenylalanine methyl ester treated human peripheral blood cells
TNSN96037A1 (en) TREATMENT OF ECZEMA
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
FR2751876B1 (en) USE OF AN OLIGOSACCHARIDE AS AN IMMUNOMODULATOR, DERMATO-COSMETIC COMPOSITION AND METHOD OF COSMETIC TREATMENT
BG102043A (en) Preparation of clavulanates
FR2741355B1 (en) COMPOSITION FOR THE TREATMENT OF OBJECTS TO BE CLEANED AND / OR DISINFECTED
AU8192691A (en) Method of treatment and compositions therefore
ITMI921559A0 (en) AMINOALKYLCARBANIC ESTERS OF ESEROLIN SUITABLE FOR USE AS ANTICHOLINESTERASES AND RELATED PREPARATION PROCEDURE
FR2756735B1 (en) AGENT FOR INHIBITING THE EXPRESSION OF THE ICAM-1 ADHESION PROTEIN AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU8353391A (en) Use of branched chain amino acids to effect diaphragm contractility and fatigue
FR2740344B1 (en) APPLICATION OF PROTEIN GAX TO THE TREATMENT OF CANCERS
ATE218877T1 (en) BOWMAN-BIRK INHIBITOR COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES
FR2724376B1 (en) PROCESS OF IN SITU TREATMENT OF SEDIMENTS AND IN PARTICULAR VASES
OA09665A (en) Hydroquinone amino acid esters, process for their preparation and pharmaceutical or cosmetic compositions containing them
FR2752739B1 (en) DEVICE FOR THE TREATMENT OF THE HUMAN BODY USING COLORED AND SOUND WAVE GENERATORS